O
IRD
Opus Genetics
4.650
+0.190+4.26%After Hours: 4.670 +0.020 +0.43%19:30 10/09 EDT
OPEN/PREV CLOSE4.460/4.460
TODAY RANGE4.450-4.740
VOL1.26M
MARKET CAP386.86M
52 WEEK RANGE1.700-7.07
AVG VOL (3M)2.39M
% TURNOVER1.27%
TURNOVER--
P/E (TTM)-3.6016
% RANGE6.50%
EPS(TTM)-1.2911
P/E(FORWARD)-4.7449
P/B-29.5990
BVPS-0.1571
DIVIDEND--
P/S22.90
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP338.66M
SHARES OUTSTANDING83.20M
NEXT EARNINGS11/10-11/24
FREE FLOAT72.83M
LOT SIZE1
EX-DATE11/06/2020
News
Press Releases
Financial Reports
Profile
Dow Jones·3d ago
Opus Genetics Is Maintained at Buy by Jones Trading
TipRanks·3d ago
Opus Genetics price target raised to $17 from $10 at Jones
Dow Jones·10/02 12:28
Opus Genetics Is Maintained at Buy by Chardan Capital
Dow Jones·10/02 12:28
Opus Genetics Price Target Maintained With a $16.00/Share by Chardan Capital
NASDAQ·09/29 09:33
Biotech Stocks Facing FDA Decision In October 2026
Seeking Alpha·09/17 13:55
Small-cap stocks with strong momentum grades and triple-digit YTD gains
TipRanks·09/12 17:15
LifeSci Capital Remains a Buy on Opus Genetics (IRD)
TipRanks·09/11 12:17
Opus Genetics Updates OPGx-BEST1 Trial Data and Outlook
Seeking Alpha·09/10 15:31
Opus Genetics: A Resounding Study Success Merits A Higher Valuation
Dow Jones·09/10 13:07
Opus Genetics Is Maintained at Outperform by Wedbush
Benzinga·09/10 12:57
Wedbush Maintains Outperform on Opus Genetics, Raises Price Target to $13
TipRanks·09/10 12:50
Analysts’ Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)